EUVIMEDEUVIMED entdecken
Leitlinie

English version of clinical practice guidelines for the management of atopic dermatitis 2024

Hidehisa Saeki iD, Yukihiro Ohya, Hirokazu Arakawa, Susumu Ichiyama iD, Toshio Katsunuma, Norito Katoh iD, Akio Tanaka iD, Hideaki Tanizaki iD, Yuichiro Tsunemi, Takeshi Nakahara, Mizuho Nagao, Masami Narita und 8 weitere

The Journal of Dermatology · 2025

DOI: 10.1111/1346-8138.17544 ↗

Kurz gefasst

Leitlinie in der Zeitschrift The Journal of Dermatology, 2025. Verfasst von Hidehisa Saeki und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Nippon Medical School, Tokyo, Japan. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Dermatologic Agents, Dermatology. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 610 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This is the English version of the 2024 clinical practice guidelines for the management of atopic dermatitis (AD). AD is a disease characterized by relapsing eczema with pruritus as a primary lesion. A crucial aspect of AD treatment is the prompt induction of remission via the suppression of existing skin inflammation and pruritus. To achieve this, topical anti‐inflammatory drugs, such as topical corticosteroids, tacrolimus ointment, delgocitinib ointment, and difamilast ointment, have been used. However, the following treatments should be considered in addition to topical therapy for patients with refractory moderate‐to‐severe AD: oral cyclosporine, subcutaneous injections of biologics (dupilumab, nemolizumab, tralokinumab), oral Janus kinase inhibitors (baricitinib, upadacitinib, abrocitinib), and phototherapy. In these revised guidelines, descriptions of five new drugs, namely, difamilast, nemolizumab, tralokinumab, upadacitinib, and abrocitinib, have been added. The guidelines present recommendations to review clinical research articles, evaluate the balance between the advantages and disadvantages of medical activities, and optimize medical activity‐related patient outcomes with respect to several important points requiring decision‐making in clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicDermatologic AgentsDermatologyHumansAdministration, OralBiological ProductsHeterocyclic Compounds, 3-RingInjections, SubcutaneousJanus Kinase InhibitorsPhototherapy

Stichwörter der Autor:innen

atopic dermatitisclinical practice guidelinesdecision‐makingevidence‐based medicinetreatment

Substanzen

Biological ProductsDermatologic AgentsHeterocyclic Compounds, 3-RingJanus Kinase Inhibitorsupadacitinib

Autor:innen und Institutionen

  • Department of Dermatology, Nippon Medical School, Tokyo, Japan.
  • Department of Occupational and Environmental Health, Graduate School of Medical Sciences and Medical School, Nagoya City University, Nagoya, Japan.
  • Kitakanto Allergy Research Institute, Kibounoie Hospital, Gunma, Japan.
  • Department of Pediatrics, The Jikei University Daisan Hospital, Tokyo, Japan.
  • Department for Medical Innovation and Translational Medical Science, Kyoto Prefectural University of Medicine Graduate School of Medical Science, Kyoto, Japan.
  • Department of Dermatology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.

ORCID-Profile: Hidehisa Saeki, Susumu Ichiyama, Norito Katoh, Akio Tanaka, Hideaki Tanizaki, Michihiro Hide, Hiroyuki Murota, Kiwako Yamamoto-Hanada, Junichi Furuta

Zitieren

APA

Saeki, H., Ohya, Y., Arakawa, H., Ichiyama, S., Katsunuma, T., Katoh, N., Tanaka, A., Tanizaki, H., Tsunemi, Y., Nakahara, T., Nagao, M., Narita, M., Hide, M., Fujisawa, T., Futamura, M., Masuda, K., Matsubara, T., Murota, H., Yamamoto-Hanada, K., & Furuta, J. (2025). English version of clinical practice guidelines for the management of atopic dermatitis 2024. The Journal of Dermatology. https://doi.org/10.1111/1346-8138.17544

Vancouver

Saeki H, Ohya Y, Arakawa H, Ichiyama S, Katsunuma T, Katoh N, et al. English version of clinical practice guidelines for the management of atopic dermatitis 2024. The Journal of Dermatology. 2025. doi:10.1111/1346-8138.17544

BibTeX
@article{Saeki2025,
  author = {Saeki, Hidehisa and Ohya, Yukihiro and Arakawa, Hirokazu and Ichiyama, Susumu and Katsunuma, Toshio and Katoh, Norito and Tanaka, Akio and Tanizaki, Hideaki and Tsunemi, Yuichiro and Nakahara, Takeshi and Nagao, Mizuho and Narita, Masami and Hide, Michihiro and Fujisawa, Takao and Futamura, Masaki and Masuda, Koji and Matsubara, Tomoyo and Murota, Hiroyuki and Yamamoto-Hanada, Kiwako and Furuta, Junichi},
  title = {English version of clinical practice guidelines for the management of atopic dermatitis 2024},
  journal = {The Journal of Dermatology},
  year = {2025},
  doi = {10.1111/1346-8138.17544}
}
Kostenlos starten →